7 . Name of Patient. Keus-( PADePMe THER Mie-Provetre Follow Up. D ae at Disease:__ . 4st e065 47-87 atl Durationgs 2nd_— Dose —__——#-+——nl 24-02 ~* Improvement: % ‘3ed—Bose—_—_—_—0.2 ml 3-03-) 4th——Dose- 0. mi torea Pl St——Dose mt 17-0 5° 0 Treatattt 6 —Dose #5 24-03-11 3th_—Dose———-4-—-td 1-3-1 8th Dose + —mt 7-4-1 these 6-14-44 - 1) 40th—Bose———t8 mk 91-4 — 11 +4th——Bose 1.8 2k Dose 0. INTERVAL BETWEEN DOSES: 07DAYS. tion Should be given subcutaneously Do not inject into a blood vessel or intramuscularly. Do not rub the site of injection, Many untoward reaction oceurs, 0,5 ml adrenaline should be gi ion should be at hand and may be given i considered advis che Allergy Ce se place in first 1/2 Hours se of severe reaction, stop vaccine immediately and cont for Half Hour inthe Clinic A ter the injection-most R Ed hare fi P ua US EN eA INST EM LIRA LU POPPI-3615(07) NIH12-12-07-1800